News & Analysis as of

State Attorneys General Abortion Food and Drug Administration (FDA)

Goodwin

Health Headlines: July 2025

Goodwin on

Welcome to the sixth issue of Health Headlines, a newsletter created by lawyers in our Healthcare practice....more

Foley Hoag LLP - State AG Insights

State Attorneys General Weigh in Amidst Supreme Court Case That Could Restrict Access to Abortion Drug Mifepristone

Attorneys general across the country have joined in litigation related to mifepristone, a drug used for medication abortions. A case currently before the Supreme Court, FDA v. Alliance for Hippocratic Medicine, could affect...more

Morrison & Foerster LLP

MoFo’s State + Local Government Enforcement Newsletter - May 2023

Morrison Foerster’s State + Local Government team is pleased to provide our bimonthly newsletter summarizing some of the most important and interesting developments from state attorneys general across the country, with links...more

Cozen O'Connor

Democratic AGs Partially Successful in Amicus Effort to Obtain Stay of Mifepristone Decision Pending Appeal

Cozen O'Connor on

A coalition of 24 Democratic AGs filed an amicus brief in the U.S. Court of Appeals for the Fifth Circuit, urging the court to stay pending the appeal of a district court’s ruling that, if allowed to take full effect, would...more

Cozen O'Connor

Republican and Democratic AGs Face Off in Texas in Latest Medication Abortion Row

Cozen O'Connor on

Forty-four AGs, evenly split into two groups of 22, have filed briefings in a Texas lawsuit in which a conservative group is challenging the FDA’s approval of mifepristone, the drug used in medication abortions....more

5 Results
 / 
View per page
Page: of 1

"My best business intelligence, in one easy email…"

Your first step to building a free, personalized, morning email brief covering pertinent authors and topics on JD Supra:
*By using the service, you signify your acceptance of JD Supra's Privacy Policy.
- hide
- hide